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Lesions occupying the uterine cavity such as endometrial polyps, 
submucous fibroids, uterine septa, and intrauterine adhesions are 
frequently seen on an ultrasonographic examination performed 
for various reasons in asymptomatic patients. The exact nature of 
these lesions can be determined by various imaging techniques 
including high-resolution transvaginal ultrasonography and 
sonohysterography. However, some of those may need to be 
confirmed by hysteroscopic directed excision. These lesions are found 
in 10-15% of subfertile women, which cause distortion of the uterine 
cavity and thus suggested to be one of the causes of subfertility [1]. 
This review will discuss the impact of uterine cavity fibroids and 
endometrial polyps on subfertility and pregnancy losses and whether 
the removal of these lesions will improve the reproductive outcome. 
UTERINE FIBROIDS
Uterine fibroids are the most common tumors of the female 
genital tract, which are found in 20-40% of women [2]. It can be 
present in any part of the uterine body or cervix and can be confined 
to the muscle wall (intramural), can form under the endometrial 
lining (submucosal), or under the serosal covering of the uterus 
(subserosal). It is estimated that fibroids may be associated with 
subfertility in 5-10% of women and are possibly the sole cause of 
subfertility in 2-3% of women [3]. Submucous, and to a lesser extent 
intramural fibroids are thought to have a negative impact on fertility 
and implantation [4-6]. Depending on the degree of uterine cavity 
distortion, fibroids are classified as type 0 if they pedunculate 100% 
into the cavity; as type I if more than 50% of the mass is within the 
cavity; and as type II if they have less than 50% of the mass within the 
cavity [2].
Impact of fibroids on fertility
Since the vast majority of women with fibroids are fertile 
and asymptomatic, it is clear that the mere presence of one or 
more fibroid(s) in a woman does not mean that her reproductive 
capability is compromised. However, fibroids do know to occur more 
frequently in women with a history of subfertility. Therefore, there is 
still a great deal of uncertainty as to whether and how the presence 
of fibroid(s) may affect a women’s fertility. Several mechanisms have 
been postulated to explain how fibroids can impair fertility:
Anatomical distortion of the uterine cavity: Fibroids that 
distort the uterine cavity, as in the case of submucosal (type 0) or 
intramural fibroid partly extended into the cavity (types I and II) can 
have an adverse effect on implantation [2]. A systemic review had 
shown that submucosal fibroids may decrease the implantation rates 
from 11.5% to 3% [5]. Therefore, it was shown that women who have 
undergone hysteroscopic resection of submucosal fibroids have a 
significant improvement in pregnancy [6,7]. Also, depending on the 
location, a submucosal fibroid may obstruct sperm migration from 
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the cervix to the fallopian tube, or cause narrowing or kinking of the 
fallopian tube.
Implantation: In addition to the distortion of the uterine cavity, 
endometrium overlying a uterine fibroid is likely to have reduced 
vascularity, which may lead to implantation failure. However, the 
precise effects of fibroids on implantation are still uncertain, and 
studies on these aspects give conflicting results [2,3].
Dysfunctional uterine contractility: Fibroids occupying the 
uterine cavity can lead to dysfunctional uterine contractility and 
thereby affect sperm migration, tubal contractility and embryo 
nidation [3].
Other mechanisms such as changes in endometrial cavity 
milieu, abnormal uterine vascularization, and chronic endometrial 
inflammation have been suggested [3,4].
The issue of whether fibroids can be the sole cause of subfertility 
has been poorly understood. This is because of the lack of prospective, 
randomized, and controlled studies separating out other subfertility 
factors. A randomized and prospective study evaluating spontaneous 
conception in subfertile women with and without fibroids found a 
significant discrepancy in pregnancy rate for subfertile women (11% 
with fibroids versus 25% without fibroids) [8]. In a recent consensus 
statement developed by a group of Australasian subspecialists in 
reproductive endocrinology and infertility (the ACCEPT group), it 
was commented that subserosal fibroids did not appear to impact 
on fertility outcomes; intramural fibroids may be associated with 
reduced fertility, and submucosal fibroids were associated with 
reduced fertility. However, the relative effect of the fibroid number 
and size upon fertility outcomes remains uncertain [9]. 
Fibroids and assisted reproductive technologies
The potential mechanisms by which fibroids could compromise 
reproductive function have already been described. It is postulated 
that uterine fibroids are associated with poorer reproductive 
outcomes in Assisted Reproductive Technologies (ART), but the 
evidence to support this is scanty and often controversial [3]. 
Overall, the evidence supports the concept that submucosal and 
intramural fibroids which distort the uterine cavity have a negative 
effect on outcomes of ART [4]. The location of the fibroids is of 
critical importance in ART outcomes [10]. Submucosal fibroids, in 
particularly, significantly reduce implantation and pregnancy rates 
of ART. It has been shown that submucosal fibroids that distort 
the uterine cavity have been found to carry a relative risk of 0.3 for 
pregnancy and 0.28 for implantation after ART, compared with 
subfertile women without fibroids [6,10]. Other authors have also 
demonstrated reduced success following ART with an odds ratio of 
0.3 for conception and 0.3 for delivery in the presence of submucosal 
fibroids [11]. The effect is not as pronounced for intramural fibroids 
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with an odds ratio of 0.62 for implantation and 0.69 for delivery per 
transfer cycle [12]. Subserosal fibroids have a negligible impact on 
fertility with ART [8,11].  
Fertility following myomectomy
Myomectomy involves removal of the fibroid(s) with 
preservation of the uterus and thus fertility. However, the actual 
effects of myomectomy on fertility remain uncertain [4]. On the 
other hand, myomectomy is associated with a risk of postoperative 
adhesion formation, which may result in further compromise of 
reproductive capacity, chronic pelvic pain, and an increased risk of 
ectopic pregnancy if conception is achieved. In addition, fibroids 
have the potential to recur such that 20-25% of women who undergo 
myomectomy require a secondary procedure [13]. Despite the lack 
of evidence from randomized studies, it does appear that surgical 
intervention for uterine fibroids does increase pregnancy rates, with 
an estimated 50% of women conceiving following myomectomy for 
fibroid-associated infertility [11]. Studies have shown that removal 
of fibroids increased the spontaneous pregnancy rate from 25% to 
42% [8], which supports the fact that fibroids influence fertility. 
Myomectomy can be performed abdominally, laparoscopically, and 
hysteroscopically. The relative effects of laparoscopic versus abdominal 
myomectomy on fertility outcomes are unknown although a recent 
multicenter randomized controlled study compared myomectomy 
performed by laparoscopy or mini-laparotomy found that both 
techniques were safe, and the size and location of the fibroid(s) were 
the strongest predictors of surgical outcome [14]. However, several 
studies had reported that hysteroscopic resection of submucous 
fibroids leads to improved pregnancy rates [3]. A systemic review also 
reported that hysteroscopic myomectomy for submucosal fibroid 
appeared likely to improve fertility outcomes [6]. Since the risks of 
hysteroscopic myomectomy are relatively few when compared to 
abdominal or laparoscopic myomectomy, the resection of submucosal 
fibroids to enhance fertility in a woman with no other obvious cause 
of subfertility is generally advocated by most reproductive medicine 
specialists [3]. Also, there is insufficient evidence to determine whether 
myomectomy for intramural fibroids improves fertility outcomes [9]. 
A recent Cochrane Database of Systematic Reviews (2012), showed no 
evidence for a significant effect of myomectomy on clinical pregnancy 
rate for intramural, submucosal, combined intramural and subserosal 
and combined intramural and submucosal fibroids, and no difference 
between laparoscopic and open approach on fertility performance 
[15]. However, this review needs to be viewed with caution due to the 
small number of studies with insufficient evidence from randomized 
controlled trials. On the other hand, hysteroscopic myomectomy 
seems to increase the odds of clinical pregnancy in women with 
unexplained subfertility and submucosal fibroids, but the evidence is 
at present still not conclusive [16]. 
Fibroids and pregnancy losses
Studies have shown that spontaneous miscarriage rates in the 
first and second trimesters of pregnancy are higher in women with 
fibroids [4]. More recent studies suggest that the rates of miscarriage 
are higher in women with submucosal fibroids [4,9]. The underlying 
mechanisms that could lead to subfertility, as outlined previously, 
could also be applicable to how fibroids could cause miscarriage. 
It seems reasonable to suppose that if implantation occurs on a 
submucosal fibroid, or on an intramural fibroid located close to 
and distorted the uterine cavity, could predispose to miscarriage. A 
miscarriage rate of 60% has been reported with fibroids which were 
reduced to 24% after myomectomy [17].  
ENDOMETRIAL POLYPS
Endometrial polyps and fertility
Endometrial polyps are a common structural uterine pathology, 
with a wide variation in the reported incidence among subfertile 
women, ranging from 1.4% to 41%, depending on the methods 
used for diagnosis and the characteristics of the populations studied 
[18,19]. However, the relationship between endometrial polyps and 
subfertility has been a matter of debate. Moreover, it is not clear 
whether removal of endometrial polyps improves implantation and 
thus the live birth rate [18]. The mechanism by which endometrial 
polyps may interfere with implantation is not clear. It is possible that 
polyps can lead to defective embryo implantation, suggested to be due 
to altered endometrial receptivity [19] or increased plasma glycodelin 
concentration [18]. The presence of an endometrial polyp may also 
induce local inflammatory changes or distort the uterine cavity, thus 
interfering with normal implantation and embryonic development 
[18]. Mittal and coauthors [20] also reported that the glands and 
stroma in endometrial polyps are unresponsive to progesterone 
stimulation. 
The usual practice of removal and histological examination of a 
polyp in subfertile women is without evidence-based support. It is 
widely accepted to remove a polyp before commencing any form 
of fertility treatment, because there is nothing to lose. Particularly, 
polypectomy has been recommended to women in whom endometrial 
polyp is the only obvious cause for their subfertility. Some benefit 
from hysteroscopic polypectomy for women who were trying to 
conceive naturally were suggested in a small perspective study, with a 
wide variation in the reported pregnancy and live birth rates [21,22].
It is not clear; however, what is the best treatment option for a 
polyp identified at the time of controlled ovarian stimulation and 
prior to fresh embryo transfer. The two options are either to proceed 
with fresh embryo transfer and consider polypectomy if treatment was 
unsuccessful or to freeze all embryos, remove the polyp and proceed 
with fresh embryo transfer three months later.In a retrospective 
case-control study, Lass, et al. [23] compared implantation and 
clinical pregnancy rates in women undergoing fresh embryo transfer 
without removal of the polyp with those who had the polyp removed 
followed by frozen embryo transfer. Only women with polyps of less 
than 20 mm were included in the study. Although there was a trend 
towards higher implantation, clinical pregnancy and live birth rates 
after polypectomy, the difference was not statistically significant. In a 
retrospective study involving 83 subfertile women with a history of the 
menstrual disorder, hysteroscopic polypectomy appeared to improve 
fertility and pregnancy rates irrespective of the size or number of 
the polyps [24]. In contrast, data from another retrospective case-
control study suggested that polyps less than 1.5  cm diagnosed by 
ultrasound scan do not require treatment prior to IVF with ICSI as 
they do not appear to have any negative effects on pregnancy and 
implantation rates [25]. In a more recent systemic review, favorable 
effects of polypectomy on pregnancy outcome can be demonstrated 
in that the hysteroscopic removal of endometrial polyps prior to IUI 
increases the odds of clinical pregnancy rate [16]. The location of the 
endometrial polyp may also influence pregnancy rate and fertility 
outcome. In a retrospective study involving 230 subfertile women 
undergoing hysteroscopy and polypectomy, the pregnancy rate 
after surgery was much better for polyps located at the utero-tubal 
junction (57.4%) than for uterine polyps in the posterior (28.5%), 
lateral (18.8%) and anterior (14.8%) uterine walls [26]. 
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While there is some evidence to suggest a detrimental effect of 
polyps on fertility, the evidence is scarce and conflicting. In general, if 
a polyp is seen prior to commencing ovarian stimulation for assisted 
reproduction, the woman should be advised for hysteroscopy and 
polypectomy. If a polyp is suspected during the course of ovarian 
stimulation prior to fresh embryo transfer, further management 
should be individualized given the number of embryos created, 
the previous reproductive history of the patient and the individual 
clinics’ success rates for their frozen embryo program. Further studies 
are needed to determine the best treatment option.
Endometrial polyps and pregnancy losses
Anatomic abnormalities account for 10% to 15% of cases of 
recurrent pregnancy losses and are generally thought to cause 
pregnancy losses by interrupting the vasculature of the endometrium, 
and prompting abnormal and inadequate placentation [27]. These 
anatomic abnormalities include congenital uterine anomalies, 
intrauterine adhesions, and uterine fibroids or polyps. In a recent 
study, endometrial polyps were identified form hysteroscopy in 7.9 
% of women following miscarriages [28]. Hysteroscopic resection is 
generally suggested if these anatomic abnormalities are identified in a 
woman with recurrent pregnancy losses [27].  
ULTRASONOGRAPHY
Uterine fibroids
The best imaging technique for visualization of fibroids is using 
the transvaginal scanning (TVS), with a curvilinear, multifrequency, 
endocavity transducer with a central frequency of 6.5 MHz. 
However, if the uterus is significantly enlarged, TVS may fail to 
visualize the whole uterus and a transabdominal scan is required. The 
transabdominal scan is performed using a multifrequency curvilinear 
abdominal transducer with a central frequency of 3.5 MHz.
The outline of a fibroid is usually well visualized, because of 
the presence of the pseudo capsule. Ultrasonographically, fibroids 
appear as heterogeneous highly attenuating echo pattern. Fibroids 
are commonly hypoechoic compared with the adjacent myometrium 
(Figure 1). However, if they undergo fatty or fibrous changes, they 
can be isoechoic or even hyperechoic. Cystic degeneration can be 
seen on ultrasound as a central anechoic area, which may sometimes 
contain internal echoes and fluid levels. Calcification can be identified 
by the presence of echogenic foci or a bright outer rim, which often 
produce posterior acoustic shadowing.  
Endometrial polyps
Ultrasonographically, an endometrial polyp should be suspected 
when ultrasound demonstrates a focal area of endometrial thickening. 
Endometrial polyps are typically echogenic in appearance (Figure 2), 
but may appear as complex lesions with echogenic tissue and cystic 
appearance. Color Doppler imaging of a polyp typically reveals a 
central feeding vessel (Figure 3), which helps to distinguish that from 
a submucous fibroid.
3D scanning
3D scanning demonstrates the uterine cavity and thus the fibroids 
and the endometrial polyps in the coronal plane. It is particularly 
useful when assessing the exact location, and size of the fibroid and the 
polyp, especially when done in conjunction with sonohysterograpy 
(Figure 4).
Figure 1: Transabdominal longitudinal sonogram showing a 7.18 X 7.66 cm 
fibroid in the posterior uterine wall.
Figure 2: Transvaginal transverse sonogram showing a 0.6 X 1.08 cm polyp 
in the endometrial lining.
Figure 3: Colour Doppler imaging of an endometrial polyp showing a central 
feeding vessel.
Saline / gel infusion sonohysterography
Saline infusion sonohysterography involves the instillation of 
normal saline into the endometrial cavity followed by transvaginal 
ultrasound examination of the uterus. It has been widely used 
in the evaluation of patients with abnormal uterine bleeding. 
The distension of endometrial cavity by normal saline improves 
visualization of the endometrial lining and therefore enhances the 
ability to detect intrauterine pathology compared to conventional 
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transvaginal sonography. Lesions occupying the endometrial cavity 
such as submucous fibroids (Figure 5A & 5B) and endometrial polyps 
(Figure 6A & 6B) can be easily and clearly visualized [29]. However, 
saline infusion sonohysterography has been found to suppress the 
color signal within the endometrium at color Doppler examination 
[30]. Recently, the gel has been proposed as an alternative to saline 
for instillation sonography [31]. Because gel has a high viscosity, 
gel-instillation  sonography is associated with less back ﬂow 
through the cervix and less transtubal ﬂow than is saline contrast 
sonohysterography. This results in a more stable ﬁlling of the uterine 
cavity. Also, gel infusion does not seem to affect the power Doppler 
signal in patients with endometrial polyps. 
Color and power Doppler
Color and power Doppler can be a useful tool in the assessment 
of the blood supply of uterine cavity lesions. It can be used to help 
distinguish between an endometrial polyp and a submucosal fibroid. 
The vascular pattern of endometrial polyps is described as a feeding 
vessel beginning from the base and going through the central part 
of the endometrium, referred to as the ‘pedicle artery sign’ [32] or 
as the ‘single-vessel pattern’ [33] (Figure 3). The power Doppler 
characteristic of submucosal ﬁbroids is described as a ‘rim-like 
Doppler pattern’, which shows a circular or semicircular vessel 
surrounding the focal endometrial lesion [34].
INTERVENTION RADIOLOGICAL TREATMENT
Uterine artery embolization
Uterine artery embolization involves the introduction of a catheter 
into the uterine artery via the femoral artery. An embolic agent (small 
synthetic particles) such as microspheres (tris-acryl gelatin) or PVA 
material (an embolus) is injected to embolize the arterial branches 
supplying the fibroid. Studies have indicated a potential improvement 
in fertility after this treatment modality [35]. However, for submucous 
fibroids which can easily be resected hysteroscopically, this treatment 
option is generally not recommended.   
High-intensity focused ultrasound
High-intensity focused ultrasound therapy has received 
increasing interest in the management of solid malignancies and 
benign tumors. In the management of uterine fibroids, high-intensity 
focused ultrasound induces focal thermocoagulation of the fibroids. 
Magnetic resonance imaging has been used to define the target for 
controlling and monitoring the ablation. Recently, sonographically 
guided high-intensity focused ultrasound has been introduced 
to monitor the ablation process [36]. Results obtained by various 
research groups have shown that using sonographically guided high-
intensity focused ultrasound for treatment of fibroids is safe, effective, 
Figure 4: 3D sonogram showing the coronal view of the uterine cavity with an 
endometrial polyp in the left uterine cornu.
Figure 5a: Saline sonohysterogram.
Figure 6a: Saline sonohysterogram.
Figure 5b: Showing multiple submucosal fibroids.Hysteroscopic view.
Figure 6b: Showing an endometrial polyp. Hysteroscopic view.
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and highly acceptable to patients [37]. A Recent study demonstrated 
significant shrinkage of submucous fibroid with the alleviation 
of symptoms using ultrasound-guided high-intensity focused 
ultrasound [38]. Several reports have suggested an improvement in 
fertility after high-intensity focused ultrasound treatment due to the 
resolution of uterine cavity distortion [39,40]. 
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